Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ngenla. Always confirm against the full prescribing information.
100 interactions
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Somatrogon.
Level 1 evidence
Alogliptin
The therapeutic efficacy of Alogliptin can be decreased when used in combination with Somatrogon.
Level 1 evidence
Amcinonide
The serum concentration of the active metabolites of Amcinonide can be reduced when Amcinonide is used in combination with Somatrogon resulting in a loss in efficacy.
Level 1 evidence
Beclomethasone dipropionate
The serum concentration of the active metabolites of Beclomethasone dipropionate can be reduced when Beclomethasone dipropionate is used in combination with Somatrogon resulting in a loss in efficacy.
Level 1 evidence
Betamethasone
The serum concentration of the active metabolites of Betamethasone can be reduced when Betamethasone is used in combination with Somatrogon resulting in a loss in efficacy.
Level 1 evidence
Bexagliflozin
The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Somatrogon.
Level 1 evidence
Bromocriptine
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Somatrogon.
Level 1 evidence
Canagliflozin
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Somatrogon.
Level 1 evidence
Abemaciclib
The metabolism of Abemaciclib can be increased when combined with Somatrogon.
Level 1 evidence
Abiraterone
The metabolism of Abiraterone can be increased when combined with Somatrogon.
Level 1 evidence
Acalabrutinib
The metabolism of Acalabrutinib can be increased when combined with Somatrogon.
Level 1 evidence
Acenocoumarol
The metabolism of Acenocoumarol can be increased when combined with Somatrogon.
Ngenla (Somatrogon-Ghla) has 678 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ngenla (Somatrogon-Ghla) has 1 major, 76 moderate, and 601 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ngenla. Always confirm against the full prescribing information.